← All patents

US20180203010A1

Angptl4 as a prognostic marker for bladder cancer

University of Texas System

Abstract

Certain embodiments are directed to methods and compositions for detecting or measuring ANGPTL4 in urinary bladder cancer sample from a subject and assessing the bladder cancer status of the subject.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Rita Ghosh
Priority date
January 17, 2017
Filing date
January 17, 2018
Publication date
July 19, 2018
Language
en
Metadata fetched
August 29, 2026 00:26